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Abstract
The Centers for Disease Control and Prevention recommends chlamydia screening at intake for all 
females in juvenile detention facilities. Identifying factors predictive of chlamydia could enable 
targeted screening, reducing costs while still identifying most infections. This study used 
demographic, arrest, and health data to identify factors associated with chlamydia among females 
aged 12 to 18 years entering a juvenile detention facility in San Diego during January 2009 to June 
2010. The study created different screening criteria based on combinations of factors associated 
with infection and calculated sensitivity and proportion screened for each criterion. Overall 
chlamydia prevalence was 10.3% and was 4.2% among females reporting no sexual risk factors. 
No acceptable targeted screening approach was identified. High prevalence, even among females 
without risk factors, supports universal screening at intake.
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Introduction
Chlamydia (caused by Chlamydia trachomatis) is a common sexually transmitted disease 
(STD) that can cause adverse reproductive health outcomes in women, including pelvic 
inflammatory disease, leading to infertility and ectopic pregnancy (Stamm, 2007). 
Chlamydia is most common among young women (Torrone, Papp, & Weinstock, 2014) and 
is usually asymptomatic (Farley, Cohen, & Elkins, 2003). Consequently, the Centers for 
Disease Control and Prevention (CDC) recommends that all sexually active women aged 24 
or younger be screened annually for chlamydia (Workowski, Bolan, & CDC, 2015). 
Chlamydia prevalence is high among incarcerated populations (Joesoef et al., 2009; 
Kouyoumdjian, Leto, John, Henein, & Bondy, 2012), including female entrants to juvenile 
correctional facilities (Joesoef et al., 2009). Therefore, the CDC recommends universal 
chlamydia screening for all females aged ≤ 35 years at intake to correctional facilities 
(Workowski, et al., 2015).
In San Diego County, California, current juvenile detention facility policy is to screen all 
females entering the facility for chlamydia using a urine-based, nucleic acid amplification 
test within 6 hours, with laboratory costs borne by the county through state prevention funds. 
Since 2003, the majority (>92% annually) of female entrants to the facility have been 
screened due to strong collaboration between the statewide Chlamydia Screening Project 
(ClaSP) and the local county probation department and their continual quality improvement 
efforts (Miller, Samoff, Bolan, & ClaSP, 2009). A review of ClaSP data for San Diego’s 
main juvenile detention facility documented high positivity (averaging 12% for chlamydia 
during 2003 to 2012 among those screened), suggesting the need to continue routine 
universal screening at the facility. However, periodically reviewing program implementation 
and outcomes can identify potential cost-reducing strategies. Identifying factors predictive of 
chlamydial infection among female entrants to juvenile detention facilities could 
theoretically allow for targeted screening, reducing costs while still identifying almost all 
infections.
Identifying effective screening criteria from ongoing screening program data can be 
problematic because data are usually biased by inadequate screening coverage (e.g., only 
females at highest risk are screened, and positivity therefore does not estimate prevalence in 
the entrant population overall). Additionally, analyses are often limited by lack of relevant 
data available (e.g., factors most predictive for chlamydial infection are not routinely 
collected). However, the San Diego juvenile detention facility had high documented 
screening coverage and the facility completes a sexual risk assessment, which includes risk 
factors for chlamydia, for every individual booked into the facility. Therefore, the San Diego 
juvenile detention facility provided an ideal setting to investigate whether chlamydia 
screening can be targeted in this type of facility.
Methods
Facility and public health laboratory records were received for all females aged 12 to 18 
years entering the San Diego juvenile detention facility during January 2009 to June 2010. 
The facility serves as the main booking location for all juvenile detention facilities in the 
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county. The screening coverage was calculated by determining the proportion of intakes in 
which the entering female was screened for chlamydia. Chlamydia prevalence was estimated 
by dividing the number of positive test results by the number of chlamydia tests done. To 
examine the factors associated with chlamydial infection, demographic, arrest, and health 
data were abstracted from the juvenile detention facility’s paper records. Data were 
abstracted on all intakes in which the female tested positive for chlamydia along with a 
random sample of 10% of intakes in which the female tested negative. Some females had 
multiple intakes during the study period and sampling was based on intakes rather than 
females. During November 2010 to July 2011, five trained abstractors from the HIV, STD, 
and hepatitis branch of the Public Health Services Division of the County of San Diego 
Health and Human Services Agency reviewed the selected records and entered abstracted 
data directly into an EpiInfo® database.
Factors known to be associated with STDs (e.g., sexual behaviors) and factors hypothesized 
to be associated with or predictive of chlamydial infection in a detention setting (e.g., reason 
for arrest) were abstracted. The current intake flow at the facility was examined and 
abstraction was restricted to data collected prior to chlamydia screening (e.g., length of stay 
in facility or outcome of arrest was not examined) so that any identified factors could be 
used to make a screening decision at the time of intake. Demographic factors abstracted 
were race, age, and whether the female was from a group home. Health-related data were 
abstracted from the assessment form completed by a nurse during the intake health exam and 
from laboratory records from previous intakes at the facility (if available in the chart). 
Health-related factors abstracted were whether the female was currently sexually active or 
currently using birth control, demonstrated prior chlamydia test result in facility record, and 
sexual risk factors. Sexual risk factors were based on self-reported answers to eight 
questions administered by a nurse: diagnosis of an STD in the past 6 months, contact with a 
person with an STD in the last 3 months, recent symptoms (e.g., discharge, dysuria, ulcer, 
rash), two or more sex partners in the last 3 months, and work as, or had sex with, a 
prostitute in the past 6 months. Arrest-related factors abstracted were arrest for drug use, sex 
work, or felony. Additionally, we considered charge code (e.g., specific offense related to the 
intake), gang affiliation, and zip code as possible factors associated with chlamydial 
infection. However, most records were missing this information or there was incomplete 
information at time of intake, so these variables were not included in the analysis.
Bivariate associations were calculated between abstracted factors and prevalent chlamydial 
infection using logistic regression with generalized estimating equations to account for 
multiple intakes among females (Kleinbaum, 2002). Different screening criteria, based on 
combinations of factors associated with infection in bivariate analysis, were created. Given 
the small sample size, a conservative of 0.10 to reduce Type II error was chosen. Screening 
criteria performance was assessed by considering the proportion of infections detected (i.e., 
sensitivity of the criteria) and the proportion of females that would be screened (i.e., 
efficiency of the criteria). All analyses were weighted to account for the sampling of intakes 
where the female tested negative for chlamydia and were conducted in SAS v.9.2 (Cary, 
North Carolina). Because this analysis was undertaken as a quality improvement activity by 
the juvenile detention facility in order to improve clinical practice, institutional review board 
Torrone et al. Page 3
J Correct Health Care. Author manuscript; available in PMC 2019 December 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
approval was not needed (U.S. Department of Health and Human Services [USDHHS], 
n.d.).
Results
During January 2009 to June 2010, there were 1,890 female intakes at the San Diego 
juvenile detention facility. A chlamydia test was performed for 1,771 of these intakes, 
representing a screening coverage of 93.7%. Overall, 10.3% (n = 183) of chlamydia tests 
were positive. Of the 183 positive tests, 163 (89.1%) intake records were available for 
review and were abstracted. Of the 1,588 negative tests at intake during the study period, 
178 intake records were randomly selected. Of those, 168 (94.4%) were available for review 
and were abstracted, representing a sample of 10.5% of all negative tests performed during 
the study period. The 331 reviewed intakes (163 chlamydia positive and 168 chlamydia 
negative) represented 294 females; 33 females had multiple intakes during the study period 
(5 females had three intakes and 27 females had two intakes).
Chlamydia prevalence varied by demographics, arrest, and health behaviors (Table 1). 
Prevalence was higher among females aged 15 to 18 years (11.1%) compared with those 
aged 12 to 14 years (4.3%; p < .10). Almost a third of females arrested for sex work (30.8%) 
had a prevalent chlamydial infection at intake. Sexually active females were more likely to 
have a prevalent infection at intake compared to females denying sexual activity (11.6% vs. 
4.2%; p < .10). Chlamydia prevalence was also higher among females reporting at least one 
STD risk factor (e.g., multiple sex partners) compared with females reporting no STD risk 
factors (23.2% vs. 7.0%; p < .10). Chlamydia prevalence was highest among females who 
had a documented prior chlamydial infection in their record at the juvenile detention facility 
at 34.6%. Chlamydia prevalence was 11.6% among African American females and 8.2% 
among non-African American females, but the difference was not statistically significant (p 
> .10).
Various screening criteria were created using combinations of the five variables associated 
with chlamydial infection in bivariate analysis (i.e., age, arrest for sex work, sexually active, 
STD risk factor, and prior positive chlamydia test in record). The most selective criteria 
would be to only screen females with all five predictive characteristics (i.e., sexually active, 
older, arrested for sex work, reported at least one STD risk factor, and had a prior positive 
chlamydia test in her record). The least selective criteria based on identified predictors 
would be to screen females who had at least one of the five markers (i.e., older age or arrest 
for sex work or sexually active or STD risk factor or prior positive chlamydia test in record). 
Criteria in between were composed of a combination of one to five of the predictive 
characteristics (e.g., screening only sexually active older females). Many combinations had 
high efficiency but low sensitivity. For example, if the facility only screened intakes where 
the arrest was related to sex work or there was a prior chlamydial infection documented in 
the record, then only 7% of intakes would require screening (i.e., high efficiency). However, 
using these criteria, only 25% of prevalent infections would be identified (i.e., poor 
sensitivity). To find 85% of all infections using combinations of factors associated with 
chlamydia, we would need to screen more than 70% of intakes. For example, screening all 
Torrone et al. Page 4
J Correct Health Care. Author manuscript; available in PMC 2019 December 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
sexually active females as well as females aged 15 years or older would identify almost all 
infections (95%) but would require screening at 87% of intakes.
Discussion
Reducing the proportion of adolescents and young adults with chlamydia is a Healthy 
People 2020 goal (USDHHS, 2014). Although increasing screening coverage is a primary 
chlamydia control strategy (Martin, 2012), periodic review of prevention efforts can help 
ensure limited resources are allocated appropriately. Using data abstracted from existing 
facility records, we demonstrate that in a juvenile detention facility in San Diego, a targeted 
screening approach—one that reduced numbers of females screened at intake while still 
capturing most chlamydia cases—could not be identified.
The San Diego facility screened young females for chlamydia at more than 94% of all 
intakes, demonstrating that high screening coverage in juvenile correctional facilities is 
feasible. This is substantially higher than the screening coverage reported in a sample of 
juvenile detention facilities nationally (average of 58% screening coverage in 2008; 
Peterman, Newman, Collins, Doshi, & Berman, 2011). It is also higher than chlamydia 
screening coverage of female adolescents in federally funded family planning clinics (57.7% 
screened in 2011; Fowler, Lloyd, Gable, Wang, & McClure, 2012) or sexually active young 
women aged 16 to 20 years accessing care in managed care organizations (54.9% screened 
in Medicaid settings in 2011; National Committee for Quality Assurance, 2012). The 
screening coverage in the San Diego facility is similar to coverage among entrants to the 
National Job Training Program, a vocational program for socioeconomically disadvantaged 
youth (94% screened in 2008; Satterwhite, Tian, Braxton, & Weinstock, 2010).
The overall observed chlamydia prevalence of 10.3% in the facility is higher than the 
prevalence in the general population of adolescent females (estimated to be ~4% in 2007 to 
2008; Datta et al., 2012) and similar to the prevalence among young women entering the 
National Job Training Program (11.4% in 2010; CDC, 2011). Prevalence in the San Diego 
facility was lower than morbidity reported in other juvenile correctional facilities in 2010 
(median facility-specific positivity was 14.5%; CDC, 2011). However, other juvenile 
correctional facilities may have targeted screening practices (e.g., only testing symptomatic 
females), resulting in higher positivity.
Targeting chlamydia screening could theoretically reduce program costs by only testing 
those females most likely to be infected. Based on an in-depth chart abstraction, we were not 
able to identify a combination of routinely collected characteristics that was both sensitive 
and efficient; no screening criteria could identify more than 85% of infections without 
requiring screening of more than 70% of intakes. Even among females reporting no sexual 
activity, prevalence of chlamydia was 4.2%, surpassing the usual cut point of 3% prevalence 
for screening cost-effectiveness (Marrazzo et al., 1997). It is possible that there is a 
combination of factors that could be used to effectively target screening in the facility but 
that those factors are not routinely collected.
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This programmatic review was subject to at least four limitations. By selecting a juvenile 
detention facility with high screening coverage, we increased the probability that positivity 
among those screened estimated prevalence in the entrant population, increasing the 
applicability of our screening criteria. However, screening was not conducted on 6% of 
intakes to the facility. If all of the females not screened were negative, the overall chlamydia 
prevalence would have been 9.6% (183/1,890); if all were positive, the prevalence would 
have been 15.9% (302/1,890). The true prevalence is between those two points. Second, 
some charts selected for review were not available during the abstraction period. It is 
possible that these missing data may have biased the findings if they were not missing at 
random. Unfortunately, reasons why the charts were not available were not known nor could 
comparisons be drawn among those females with and without available charts. Hence, it was 
assumed the charts were missing at random. However, as more than 90% of total charts 
selected for review were available, the effect of missing data should be minimal. Third, the 
“sexually active” variable did not capture sexual activity within a specific time period. It is 
possible that a more nuanced question (e.g., “have you had sex in the last month”) would be 
a stronger predictor of chlamydial infection. Finally, these findings may not be generalizable 
to all juvenile detention facilities. However, this assessment was conducted using routinely 
collected data in the facility. Local and regional facilities could conduct their own analysis to 
see if facility-relevant screening criteria could be identified.
Chlamydial infections can cause lifelong, reproductive health consequences, and identifying 
and treating infections in young women is a public health priority. Young females entering 
detention facilities are at increased risk for chlamydial infection and are often 
disenfranchised from routine health care (Spaulding et al., 2013). Screening upon intake to a 
detention facility offers an opportunity to reduce adverse sequelae in a vulnerable, at-risk 
population. Our findings support the current recommendation of screening of all young 
females at intake to correctional facilities.
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Table 1.
Associations Between Demographic, Arrest, and Health-Related Factors and Prevalent Chlamydial Infection 
Among Females Aged 12 to 18 Years Screened at Intake to Juvenile Detention Facility, San Diego, California, 
January 2009 to June 2010.
Weighted Totala No. With Chlamydial Infection (n = 163) Percentage With Chlamydial Infection
Demographics
 Race
  African American 524 61 11.6
  Non-African American 1,214 99 8.2
 Age (years)
  12–14 444 19 4.3**
  15–18 1,265 140 11.1
 From a group home
  Yes 135 12 8.9
  No 1,554 146 9.4
Arrest data
 Arrest for drugs
  Yes 108 13 12.1
  No 1,620 145 9.0
 Arrest for sex work
  Yes 68 21 30.8
  No 1,659 137 8.3
 Felony arrest
  Yes 624 57 9.1
  No 1,102 100 9.1
Health behaviors
 Sexually active
  Yes 1,177 137 11.6**
  No 543 23 4.2
 No. of STD risk factorsb
  ≥1 246 57 23.2**
  0 1,505 106 7.0
 Currently using birth control
  Yes 276 30 10.9
  No 1,444 130 9.0
Prior chlamydia test at facility
 Positive prior test 72 25 34.6**
 No or negative prior test 1,679 138 8.2
Note. STD = sexually transmitted disease.
aWeighted to reflect all females tested in facility during study period (N = 1,771), which may not add to total due to missing data.
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b
Based on self-reported answers to eight questions: diagnosed with STD (last 6 months), traded sex (last 6 months), contact to STD (last 3 
months), multiple sex partners (last 3 months), or recent signs or symptoms of STDs.
**p for difference in percentage with chlamydial infection < .10.
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